Clinical trials: Permanent Pacemaker Implantation

Atrial Fibrillation, Arrythmia

Arrythmia Burden in Cardiac Contractility Modulation (CCM)

• Terminated
• Age: 18 years and older
• Observational study
• Medical device
• Results posted

The Impulse Dynamics Optimizer Device is a Food and Drug Administration (FDA) approved; commercially available device indicated for patients with heart failure with reduced ejection fraction (HFrEF).

Trial name

ABC (NCT05704426)

Testing

Impulse Dynamics Optimizer Device

Where

United States

Volunteers

2 people

Sponsor

Hackensack Meridian Health